OssDsign AB (publ)

OM:OSSD Stock Report

Market Cap: SEK 439.7m

OssDsign Valuation

Is OSSD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OSSD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: Insufficient data to calculate OSSD's future cash flow value for valuation analysis.

Significantly Below Future Cash Flow Value: Insufficient data to calculate OSSD's future cash flow value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OSSD?

Key metric: As OSSD is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for OSSD. This is calculated by dividing OSSD's market cap by their current revenue.
What is OSSD's PS Ratio?
PS Ratio2.5x
SalesSEK 172.55m
Market CapSEK 439.74m

Price to Sales Ratio vs Peers

How does OSSD's PS Ratio compare to its peers?

The above table shows the PS ratio for OSSD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average5.3x
BIOWKS Bio-Works Technologies
4.1xn/aSEK 338.0m
BACTI B Bactiguard Holding
2.5x12.15%SEK 525.7m
XVIVO Xvivo Perfusion
9.7x23.95%SEK 8.7b
IMS Invent Medic Sweden
4.9xn/aSEK 32.9m
OSSD OssDsign
2.5x24.57%SEK 439.7m

Price-To-Sales vs Peers: OSSD is good value based on its Price-To-Sales Ratio (2.5x) compared to the peer average (5.3x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does OSSD's PS Ratio compare vs other companies in the SE Medical Equipment Industry?

15 CompaniesPrice / SalesEstimated GrowthMarket Cap
ARJO B Arjo
0.7x3.85%US$824.03m
ADDV A ADDvise Group
0.6x3.82%US$115.93m
CARE Careium
0.8x6.99%US$72.57m
BOUL Boule Diagnostics
0.3x4.58%US$13.43m
OSSD 2.5xIndustry Avg. 4.3xNo. of Companies15PS048121620+
15 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: OSSD is good value based on its Price-To-Sales Ratio (2.5x) compared to the Swedish Medical Equipment industry average (4.3x).

Price to Sales Ratio vs Fair Ratio

What is OSSD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OSSD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.5x
Fair PS Ratio7.8x

Price-To-Sales vs Fair Ratio: OSSD is good value based on its Price-To-Sales Ratio (2.5x) compared to the estimated Fair Price-To-Sales Ratio (7.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OSSD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 3.98
SEK 6.00
+50.94%
23.57%SEK 8.00SEK 5.00n/a3
Aug ’27SEK 4.28
SEK 6.40
+49.53%
28.73%SEK 9.00SEK 5.10n/a3
Jul ’27SEK 4.07
SEK 6.40
+57.25%
28.73%SEK 9.00SEK 5.10n/a3
Jun ’27SEK 3.92
SEK 6.40
+63.27%
28.73%SEK 9.00SEK 5.10n/a3
May ’27SEK 4.10
SEK 8.40
+105.13%
55.56%SEK 15.00SEK 5.10n/a3
Apr ’27SEK 6.46
SEK 12.75
+97.37%
17.65%SEK 15.00SEK 10.50n/a2
Mar ’27SEK 6.47
SEK 12.75
+97.06%
17.65%SEK 15.00SEK 10.50n/a2
Feb ’27SEK 9.25
SEK 14.50
+56.76%
20.69%SEK 17.50SEK 11.50n/a2
Jan ’27SEK 11.34
SEK 15.50
+36.68%
12.90%SEK 17.50SEK 13.50n/a2
Dec ’26SEK 10.68
SEK 15.50
+45.13%
12.90%SEK 17.50SEK 13.50n/a2
Nov ’26SEK 13.00
SEK 16.25
+25.00%
10.77%SEK 18.00SEK 14.50n/a2
Oct ’26SEK 14.24
SEK 15.00
+5.34%
16.33%SEK 18.00SEK 12.00n/a3
Sep ’26SEK 15.68
SEK 15.00
-4.34%
16.33%SEK 18.00SEK 12.00n/a3
Aug ’26SEK 15.22
SEK 14.83
-2.54%
15.16%SEK 17.50SEK 12.00SEK 4.283
Jul ’26SEK 14.72
SEK 14.83
+0.77%
15.16%SEK 17.50SEK 12.00SEK 4.073
Jun ’26SEK 14.40
SEK 13.33
-7.41%
9.35%SEK 15.00SEK 12.00SEK 3.923
May ’26SEK 13.30
SEK 13.00
-2.26%
6.28%SEK 14.00SEK 12.00SEK 4.103
Apr ’26SEK 11.34
SEK 13.00
+14.64%
6.28%SEK 14.00SEK 12.00SEK 6.463
Mar ’26SEK 13.68
SEK 13.00
-4.97%
6.28%SEK 14.00SEK 12.00SEK 6.473
Feb ’26SEK 10.30
SEK 12.00
+16.50%
6.80%SEK 13.00SEK 11.00SEK 9.253
Jan ’26SEK 9.86
SEK 12.00
+21.70%
6.80%SEK 13.00SEK 11.00SEK 11.343
Dec ’25SEK 9.00
SEK 12.00
+33.33%
6.80%SEK 13.00SEK 11.00SEK 10.683
Nov ’25SEK 6.48
SEK 12.33
+90.33%
10.11%SEK 14.00SEK 11.00SEK 13.003
Oct ’25SEK 6.58
SEK 12.33
+87.44%
10.11%SEK 14.00SEK 11.00SEK 14.243
Sep ’25SEK 7.43
SEK 12.33
+65.99%
10.11%SEK 14.00SEK 11.00SEK 15.683
Aug ’25SEK 9.14
SEK 13.17
+44.06%
15.29%SEK 16.00SEK 11.50SEK 15.223
SEK 6
Fair Value
33.8% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/20 05:04
End of Day Share Price 2026/08/20 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OssDsign AB (publ) is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
null nullABG Sundal Collier Sponsored
Kristofer Liljeberg-SvenssonDNB Carnegie Commissioned Research